# Bigevidence

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bigevidence

- Industry: Healthcare IT
- Headquarters: Los Angeles, US
- Website: www.bigevidence.com
- Total disclosed funding: $0M
- Latest round: Seed (Jun 1, 2011)
- Investors on record: 1

## About

Bigevidence provides a specialized platform for domain pricing and valuation services, enabling clients to receive accurate domain price estimates efficiently, enhancing their digital asset acquisition decisions.Bigevidence operates a platform focused on domain pricing and valuation services. The company is headquartered in Los Angeles, US. In June 2011, Bigevidence raised USD 0.02 mn in Seed funding from Rock Health, marking a significant step in its growth strategy.BigEvidence.com offers a streamlined platform designed to help clients obtain domain pricing and valuation services efficiently. The core service allows users to receive domain price estimates within 24 business hours, facilitated by a team of domain experts who evaluate various factors influencing domain value. This service targets a diverse clientele, including individual entrepreneurs, small businesses, and larger enterprises looking to acquire or invest in premium domain names. By catering to a broad spectrum of users, BigEvidence.com addresses the challenges of domain valuation, which can often be complex and time-sensitive. The company serves customers primarily in North America and Europe, providing valuable insights and pricing information for the global digital marketplace.Revenue generation at BigEvidence.com is primarily based on transactional services related to domain valuation. Clients engage with the platform by submitting requests for pricing estimates, which are processed promptly, creating a structured transaction flow. While specific pricing plans for these valuation services are not disclosed, the business model suggests a direct-to-consumer approach where clients pay for expert assessments based on their specific domain needs. The company’s flagship offering revolves around its rapid pricing service, which plays a crucial role in facilitating informed decision-making for potential buyers. Overall, the revenue structure is designed to support a seamless user experience while providing essential valuation insights to a diverse range of clients.In the near future, Bigevidence plans to expand its offerings by introducing new features for enhanced domain valuation services. The company aims to broaden its market presence, particularly targeting European and Asian markets by the end of 2023. The recent Seed funding of USD 0.02 mn will be utilized to develop these new products and support marketing efforts in the specified regions.

## Funding rounds

- Seed, Jun 1, 2011, $0M — Rock Health

## Investors

- Rock Health (https://capitalatlas.ai/funds/rock-health) — Seed